Automatic translation by Google. Limitations and info.
Public health driven innovation is key
A public health driven and end-to-end approach to innovation that enables sustainable access to effective antibiotics in low- and middle-income countries is broadly supported. Learn more about the whys and hows.
The world needs new antibiotics – so why aren’t they developed?
Effective antibiotics are a cornerstone of basic and specialized medicine. The emergence of resistance in bacteria to antibiotics is slowly dismantling our ability to treat infections, alleviate human suffering, and save lives. The COVID-19 pandemic is a clear reminder of the deadly consequences the world faces, when we do not have the right treatments or vaccines available when needed.
ReAct Report: Governments need to take more leadership to ensure global sustainable access to effective antibiotics
While the world is caught up in responding to the COVID-19 pandemic, it has gone largely unnoticed that more than thirty years has passed since the last class of antibiotics was discovered. Meanwhile global consumption of antibiotics continues to increase. In response, bacteria have developed resistance and are spreading as a silent but steady pandemic threatening to devastate healthcare and modern medicine as we know it. Read more about the release of the report and download full report.